Sex-related Differences in Risk Factors, Type of Treatment Received and Outcomes in Patients with Atrial Fibrillation and Acute Stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke And...

Introduction: Atrial fibrillation is an independent risk factor of thromboembolism. Women with atrial fibrillation are at a higher overall risk for stroke compared to men with atrial fibrillation. The aim of this study was to evaluate for sex differences in patients with acute stroke and atrial fibrillation, regarding risk factors, treatments received and outcomes.

Methods: Data were analyzed from the "Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation" (RAF-study), a prospective, multicenter, international study including only patients with acute stroke and atrial fibrillation. Patients were followed up for 90 days. Disability was measured by the modified Rankin Scale (0-2 favorable outcome, 3-6 unfavorable outcome).

Results: Of the 1029 patients enrolled, 561 were women (54.5%) ( < 0.001) and younger ( < 0.001) compared to men. In patients with known atrial fibrillation, women were less likely to receive oral anticoagulants before index stroke ( = 0.026) and were less likely to receive anticoagulants after stroke (71.3% versus 78.4%, = 0.01). There was no observed sex difference regarding the time of starting anticoagulant therapy between the two groups (6.4 ± 11.7 days for men versus 6.5 ± 12.4 days for women, = 0.902). Men presented with more severe strokes at onset (mean NIHSS 9.2 ± 6.9 versus 8.1 ± 7.5, < 0.001). Within 90 days, 46 (8.2%) recurrent ischemic events (stroke/TIA/systemic embolism) and 19 (3.4%) symptomatic cerebral bleedings were found in women compared to 30 (6.4%) and 18 (3.8%) in men ( = 0.28 and = 0.74). At 90 days, 57.7% of women were disabled or deceased, compared to 41.1% of the men ( < 0.001). Multivariate analysis did not confirm this significance.

Conclusions: Women with atrial fibrillation were less likely to receive oral anticoagulants prior to and after stroke compared to men with atrial fibrillation, and when stroke occurred, regardless of the fact that in our study women were younger and with less severe stroke, outcomes did not differ between the sexes.

Citing Articles

Associations of Social, Behavioral, and Clinical Factors With Sex Differences in Stroke Recurrence and Poststroke Mortality.

Chen C, Reeves M, He K, Morgenstern L, Lisabeth L Circ Cardiovasc Qual Outcomes. 2025; 18(2):e011082.

PMID: 39817333 PMC: 11835519. DOI: 10.1161/CIRCOUTCOMES.124.011082.

Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study.

Wang J, Du X, Dong J, Chang S, Jiang C, Sang C Clin Cardiol. 2021; 45(1):60-67.

PMID: 34952974 PMC: 8799037. DOI: 10.1002/clc.23759.

References

Kapral M, Fang J, Hill M, Silver F, Richards J, Jaigobin C . Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke. 2005; 36(4):809-14. DOI: 10.1161/01.STR.0000157662.09551.e5. View

Fang M, Singer D, Chang Y, Hylek E, Henault L, Jensvold N . Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005; 112(12):1687-91. PMC: 3522521. DOI: 10.1161/CIRCULATIONAHA.105.553438. View

Dagres N, Nieuwlaat R, Vardas P, Andresen D, Levy S, Cobbe S . Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007; 49(5):572-7. DOI: 10.1016/j.jacc.2006.10.047. View

Hart R, Pearce L, Aguilar M . Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007; 146(12):857-67. DOI: 10.7326/0003-4819-146-12-200706190-00007. View

Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A . Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke. 2008; 39(8):2249-56. DOI: 10.1161/STROKEAHA.107.510321. View

Gladstone D, Bui E, Fang J, Laupacis A, Lindsay M, Tu J . Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2008; 40(1):235-40. DOI: 10.1161/STROKEAHA.108.516344. View

Eriksson M, Glader E, Norrving B, Terent A, Stegmayr B . Sex differences in stroke care and outcome in the Swedish national quality register for stroke care. Stroke. 2009; 40(3):909-14. DOI: 10.1161/STROKEAHA.108.517581. View

Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H . Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2009; 137(2):263-72. DOI: 10.1378/chest.09-1584. View

Wang D, Liu M, Hao Z, Tao W, Lin S, Zhang S . Features of acute ischemic stroke with rheumatic heart disease in a hospitalized Chinese population. Stroke. 2012; 43(11):2853-7. DOI: 10.1161/STROKEAHA.112.670893. View

10.

Santalucia P, Pezzella F, Sessa M, Monaco S, Torgano G, Anticoli S . Sex differences in clinical presentation, severity and outcome of stroke: results from a hospital-based registry. Eur J Intern Med. 2012; 24(2):167-71. DOI: 10.1016/j.ejim.2012.10.004. View

11.

Saposnik G, Gladstone D, Raptis R, Zhou L, Hart R . Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke. 2012; 44(1):99-104. DOI: 10.1161/STROKEAHA.112.676551. View

12.

Reboldi G, Angeli F, Verdecchia P . Multivariable analysis in cerebrovascular research: practical notes for the clinician. Cerebrovasc Dis. 2013; 35(2):187-93. DOI: 10.1159/000345491. View

13.

Cove C, Albert C, Andreotti F, Badimon L, van Gelder I, Hylek E . Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost. 2013; 111(3):385-91. DOI: 10.1160/TH13-04-0347. View

14.

Jespersen S, Christensen L, Christensen A, Christensen H . Use of oral anticoagulation therapy in atrial fibrillation after stroke: results from a nationwide registry. Thrombosis. 2013; 2013:601450. PMC: 3855960. DOI: 10.1155/2013/601450. View

15.

Gattringer T, Ferrari J, Knoflach M, Seyfang L, Horner S, Niederkorn K . Sex-related differences of acute stroke unit care: results from the Austrian stroke unit registry. Stroke. 2014; 45(6):1632-8. DOI: 10.1161/STROKEAHA.114.004897. View

16.

Bushnell C, McCullough L . Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline. Ann Intern Med. 2014; 160(12):853-7. PMC: 4255708. DOI: 10.7326/M14-0762. View

17.

Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S . Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study. Stroke. 2015; 46(8):2175-82. DOI: 10.1161/STROKEAHA.115.008891. View

18.

Wolpert S, Bruckmann H, Greenlee R, Wechsler L, Pessin M, Del Zoppo G . Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol. 1993; 14(1):3-13. PMC: 8334451. View

19.

Tatu L, Moulin T, Bogousslavsky J, DUVERNOY H . Arterial territories of human brain: brainstem and cerebellum. Neurology. 1996; 47(5):1125-35. DOI: 10.1212/wnl.47.5.1125. View

20.

Tatu L, Moulin T, Bogousslavsky J, DUVERNOY H . Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998; 50(6):1699-708. DOI: 10.1212/wnl.50.6.1699. View